Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Avadel Pharmaceuticals Plc ADR (AVDL)
Avadel Pharmaceuticals Plc ADR (AVDL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Avadel: Q3 Earnings Snapshot

Avadel: Q3 Earnings Snapshot

AVDL : 14.19 (+3.65%)
Avadel: Q2 Earnings Snapshot

Avadel: Q2 Earnings Snapshot

AVDL : 14.19 (+3.65%)
Why Shares of Avadel Soared This Week

The company got its first FDA approval.

JAZZ : 120.42 (+0.73%)
AVDL : 14.19 (+3.65%)
Avadel: Q1 Earnings Snapshot

Avadel: Q1 Earnings Snapshot

AVDL : 14.19 (+3.65%)
Avadel: Q4 Earnings Snapshot

Avadel: Q4 Earnings Snapshot

AVDL : 14.19 (+3.65%)
Avadel: Q3 Earnings Snapshot

Avadel: Q3 Earnings Snapshot

AVDL : 14.19 (+3.65%)
Avadel Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2022 Financial Results

Received tentative approval for LUMRYZ™ (sodium oxybate) extended-release for oral suspension from FDA on July 18Advancing key activities to potentially...

AVDL : 14.19 (+3.65%)
Wall Street Analysts Think Avadel (AVDL) Could Surge 106%: Read This Before Placing a Bet

The average of price targets set by Wall Street analysts indicates a potential upside of 105.6% in Avadel (AVDL). While the effectiveness of this highly sought-after metric is questionable, the positive...

AVDL : 14.19 (+3.65%)
Avadel Pharmaceuticals to Provide a Corporate Update and Report Second Quarter Financial Results on August 9

DUBLIN, Ireland, Aug. 02, 2022 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming...

AVDL : 14.19 (+3.65%)
Avadel Pharmaceuticals Announces Tentative Approval of LUMRYZ™ (sodium oxybate) extended-release oral suspension

- Validates the safety profile and clinical efficacy of LUMRYZ - Pursuing strategies to accelerate final approval DUBLIN, Ireland, July 19, 2022 (GLOBE...

AVDL : 14.19 (+3.65%)

Barchart Exclusives

3 Gold Mining Stocks to Buy for More Upside
As gold futures solidify their footing above $2,000 an ounce, here's a look at three gold mining stocks that Wall Street expects to rally from current levels. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar